Viral hepatitis Flashcards

1
Q

Acute response of liver to hepatotropic viruses: Direct cytopathic vs immune-mediated

A

Both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Necrosis in viral hepatitis is most marked in what area

A

Centrilobular areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inflammatory infiltrates are settles in what area in cases of chronic hep

A

Inflammatory infiltrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neonates often respond to hepatic injury by forming

A

Giant cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Viral hepatitis T/F Rapidly falling aminotransferase levels reflect poor outcome

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most important marker of liver injury

A

Altered synthetic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most prevalent of the hepatotropic viruses

A

Hepatitis A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hepa viruses: Responsible for most forms of acute and benign hepatitis

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hepa viruses: RNA

A

A, C, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hepa viruses: Picornavirus

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hepa A transmission

A

Person-to-person through fecal-oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F Hepa A is responsible for ACUTE hepatitis only

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hepa A infection is diagnosed by

A

Anti-HAV IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 distinct complications of Hepa A infection

A

1) Acute liver failure, usually in adolescents and adults 2) Prolonged cholestatic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hepa A treatment

A

None specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patients infected with HAV are contagious when

A

2 weeks before and 7 days after onset of jaundice (should be excluded from school, child care, or work)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Indications for IM administration of Ig and vaccine (pre- and post-exposure)

A

1) Ig for susceptible travelers to countries where HAV is endemic 2) Vaccine for healthy persons prior to travel 3) Ig for <1 y/o, patients allergic to vaccine component, or those who elect not to receive vaccine 4) Ig postexposure EXCLUSIVELY for <12 months, immunocompromised, chronic liver disease, or if vaccine is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hepa viruses: DNA

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hepa viruses: Hepadnaviridae

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hepa B: Serves as a marker of active viral replication

A

HBeAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Correlates with HBV DNA levels

A

HBeAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hepa B transmission

A

Blood transfusion and sexual contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Most important risk factor for acquisition of HBV in children

A

Perinatal exposure to an HBsAg positive mother

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T/F Breastfeeding of nonimmunized infants by infected motgers confers a greater risk of hepatitis than formula feeding

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Chronic HBV infection is defined as

A

Positive HBsAg for >6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

T/F Risk of developing chronic HBV infection is inversely related to age of acquisition

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Most prevalent cancer-related death in young adults in Asia where HBV is endemic

A

Hep B hepatocellular carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Hepa B: Direct cytopathic vs immune-mediated

A

Immune-mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

First biochemical evidence of HBV infection

A

Elevation of ALT (begins to rise just before development of fatigue, anorexia, and malaise)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

First serologic marker of infection to appear in HBV infection

A

HBsAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

HBV infection: During recovery from acute infection, ___ might be the only marker of acute infection

A

HBc IgM (since HBsAg levels fall before symptoms wane)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

HBV infection: Valuable serologic marker of acute HBV infection as it rises early after the infection and remains positive for many months

A

Anti-HBc

33
Q

HBV infection: Marks serologic recovery and protection

A

Anti-HBs

34
Q

HBV infection: Only this serologic marker is present in persons immunized with Hep B vaccine

A

Anti-HBs

35
Q

HBV infection: Marker of infectivity

A

HBeAg

36
Q

T/F: HBeAg is present in active acute and chronic infection

A

T

37
Q

HBV infection: Development of ___ marks improvement and is goal of therapy in chronically infected patients

A

Anti-HBe

38
Q

Hepa viruses: Acute liver failure occurs more commonly with ___ than with other hepatotropic viruses

A

Hepa B

39
Q

T/F Treatment of acute HBV infection is largely supportive

A

T

40
Q

Goal of treatment in chronic HBV infection

A

Reduce viral replication

41
Q

Reduction of viral replication in HBV infection is defined by

A

1) Undetectable HBV DNA in the serum 2) Development of anti-HBe

42
Q

Hepa B: Treatment is only indicated for

A

Patients in immune-active form with evidence of ongoing inflammation and fibrosis, putting the child at higher risk for cirrhosis during childhood

43
Q

Hepa B treatment: Immunomodulator with antiviral effects

A

IF-α-2b

44
Q

Hepa B treatment: Oral synthetic nucleoside analog that inhibits viral enzyme reverse transcriptase

A

Lamivudine

45
Q

Hepa C: Most prevalent mode of transmission

A

Perinatal

46
Q

Hepa C: Direct cytopathic vs immune-mediated

A

Cytopathic

47
Q

Most likely hepatotropic virus to cause chronic infection

A

Hepa C

48
Q

Hepa viruses: Infection is associated with small vessel vasculitis

A

Hepa C

49
Q

Hepa viruses: Infection is associated with essential mixed cryoglobulinemia

A

Hepa C

50
Q

Hepa C: Most widely used serologic test

A

3rd generation EIA to detect anti-HCV

51
Q

Hepa C: Most widely used virologic assay

A

PCR assay that detects HCV RNA

52
Q

Hepa C: Most effective treatment in adults

A

Peg interferon combined with oral Ribavirin

53
Q

Hepa C: Goal of treatment

A

Sustained viral response

54
Q

Hepa C: Sustained viral response is defined as

A

Absence of viremia 6 months after stopping medications

55
Q

T/F There is no vaccine available to prevent Hepa C

A

T

56
Q

Annual tests done for patients in whom HCV infection is identified

A

1) Liver ultrasound 2) Serum AFP for HCC

57
Q

Smallest known animal virus which is considered to be defective

A

Hepa D

58
Q

Why is Hepa D considered to be defective

A

Cannot produce infection without concurrent HBV infection

59
Q

T/F Concurrent infection of Hepa D with Hepa B takes 2 forms - co-infection (at the same time) or superinfection (infect a person already infected with Hepa B

A

T

60
Q

Hepa D: Direct cytopathic vs immune-mediated

A

Cytopathic

61
Q

HDV-HBV co-infection vs superinfection: Acute hepatitis > chronic hepatitis

A

Co-infection

62
Q

HDV-HBV co-infection vs superinfection: Chronic hepatitis > acute hepatitis

A

Superinfection

63
Q

HDV-HBV co-infection vs superinfection: Risk for ALF is highest

A

Superinfection

64
Q

T/F HDV must be considered in all cases of acute liver failure

A

T

65
Q

Diagnosis of HDV infection is made by detecting

A

HDV IgM

66
Q

T/F There are no specific HDV-targeted treatments

A

T

67
Q

Hepa viruses: Similar in structure to caliciviruses

A

HEV

68
Q

Hepa viruses: Epidemic form was formerly called non-A, non-B hepatitis

A

HEV

69
Q

HEV: Transmission

A

Fecal-oral

70
Q

HEV: Direct cytopathic vs immune-mediated

A

Cytopathic

71
Q

T/F Chronic illness does not occur in HEV infection

A

T

72
Q

Hepa viruses: Major pathogen in pregnant women in whom it causes ALF with a high fatality incidence

A

HEV

73
Q

Hepa viruses: Flavivirus

A

HCV, HEV, HGV

74
Q

HAV incubation period

A

15-30 days

75
Q

HBV incubation period

A

60-180 days

76
Q

HCV incubation period

A

30-69 days

77
Q

HEV incubation period

A

35-60 days

78
Q

Hepa viruses: Causes chronic infection in 90% of patients when acquired perinatally

A

HBV

79
Q

Hepa viruses: Increased risk of hepatocellular carcinoma

A

HBV and HCV